#  Thomas Beauchamp (Eli Lilly)  

 



####  calendar\_today Date and Time 

 **April 11, 2024** 

 03:15PM - 04:15PM EDT 

####  pin\_drop Location 

 **Pfizer Lecture Hall**  



 

 



 

 Title: Process Development of the IL-17A Inhibitor LY3509754

 This talk will provide a brief description of why Eli Lilly feels the development of a small

 molecule IL-17 inhibitor will provide significant benefit to patients suffering from autoimmune

 disease.

 The focus of the talk will be on the route scouting and early process development effort that was

 executed to prepare kilogram quantities of drug substance for the first human dose trial, and the

 outcome of that trial will be discussed.



 

 



 

 See also:- [ Eli Lilly Symposium ](/seminar-series/eli-lilly-symposium)
 
 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)
 


 Save: [ Add to calendar calendar\_today ](https://www.chemistry.harvard.edu/node/1574631/event-feed.ics)  Copy link link